India's Ipca Laboratories Halts Shipments To U.S. From Local Plant After FDA Concerns

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - India's Ipca Laboratories Ltd said on Thursday it has voluntarily suspended shipments to the United States from one of its drug ingredient manufacturing plants after the U.S. Food and Drug Administration (FDA) expressed concerns regarding the unit.

Help employers find you! Check out all the jobs and post your resume.

Back to news